China to expand COVIDQQ19 vaccine manucturing capacity

The Ministry of Industry and Information Technology (MIIT) has moved to cilitate corporate cooperation along industrial chains to accelerate the industrialization of COVID-19 vaccines and expand production capacity to ensure the supply of vaccines, an official said Tuesday.


Production plans will be properly arranged to maximize production potential and ensure the supply of COVID-19 vaccines, Wang said.

To ensure a stable supply chain for vaccine production, the country has also stepped up efforts to achieve breakthroughs in the production of core materials, and helped match the supply and demand of upstream and downstream firms.

The ministry has established a special work team to track and coordinate vaccine production by key producers on a weekly basis.

Zhang Jin, a manager at the China National Biotec Group, said the company will implement a plan to expand production capacity and to ensure that more than one billion doses of inactivated COVID-19 vaccines are produced this year.

With 18 Chinese enterprises starting to build production capacity for COVID-19 vaccines so r, further improvement of the manucturing capacity of the inactivated vaccines will allow China to meet its huge vaccination demand, according to the MIIT.

Wang Jiangping, vice minister of industry and information technology, said the countrys production capacity will be steadily expanded while ensuring the quality and safety of vaccines.